Functional Foods: An Approach to Modulate Molecular Mechanisms of Alzheimer's Disease

Cells. 2020 Oct 23;9(11):2347. doi: 10.3390/cells9112347.

Abstract

A new epoch is emerging with intense research on nutraceuticals, i.e., "food or food product that provides medical or health benefits including the prevention and treatment of diseases", such as Alzheimer's disease. Nutraceuticals act at different biochemical and metabolic levels and much evidence shows their neuroprotective effects; in particular, they are able to provide protection against mitochondrial damage, oxidative stress, toxicity of β-amyloid and Tau and cell death. They have been shown to influence the composition of the intestinal microbiota significantly contributing to the discovery that differential microorganisms composition is associated with the formation and aggregation of cerebral toxic proteins. Further, the routes of interaction between epigenetic mechanisms and the microbiota-gut-brain axis have been elucidated, thus establishing a modulatory role of diet-induced epigenetic changes of gut microbiota in shaping the brain. This review examines recent scientific literature addressing the beneficial effects of some natural products for which mechanistic evidence to prevent or slowdown AD are available. Even if the road is still long, the results are already exceptional.

Keywords: Alzheimer; brain; cell death; diet; epigenetics; gut microbiota; health; nutraceuticals.

Publication types

  • Review

MeSH terms

  • Alzheimer Disease / etiology
  • Alzheimer Disease / metabolism*
  • Alzheimer Disease / therapy
  • Amyloid beta-Peptides / metabolism
  • Animals
  • Biological Products / pharmacology
  • Biomarkers
  • Brain / drug effects
  • Brain / metabolism
  • Brain / pathology
  • DNA Methylation
  • Diet Therapy
  • Dietary Supplements
  • Disease Management
  • Disease Susceptibility
  • Functional Food*
  • Gastrointestinal Microbiome / drug effects
  • Gene Expression Regulation / drug effects
  • Humans
  • Mitochondria / drug effects
  • Mitochondria / genetics
  • Mitochondria / metabolism
  • Neuroprotective Agents / pharmacology

Substances

  • Amyloid beta-Peptides
  • Biological Products
  • Biomarkers
  • Neuroprotective Agents